Middle East Business: Novartis collaborates with UAE’s Pharmax Pharmaceuticals – Gulf Digital News

Middle East Business: Novartis collaborates with UAE’s Pharmax Pharmaceuticals – Gulf Digital News

Novartis, a leading global medicines company, today (March 3) announced a strategic partnership with UAE-based Pharmax Pharmaceuticals, which manufactures and markets affordable, branded generic medication.

In line with the vision of UAE’s Ministry of Health and Prevention to encourage partnerships between research-based pharmaceutical companies and manufacturers in the UAE, the collaboration covers the commercialization and co-marketing of Novartis products to Pharmax to enhance patient access to medicines and treatments in a range of Cardiometabolic diseases such as Diabetes and Hypertension.

Both companies formalised their partnership at a signing ceremony held at the Swiss Pavilion, Dubai Expo 2020 in the presence of Massimo Baggi, Ambassador of Switzerland to UAE and Bahrain; Marwan Abdul Aziz, Managing Director at Dubai Science Park; Mohamed Ezz Eldin, President and Head of Gulf Cluster at Novartis Pharmaceuticals; Fahad Al Qassim, Chairman of Pharmax, and Madhukar Tanna, CEO at Pharmax Pharmaceuticals.

“Our vision is to foster an effective and sustainable healthcare system that contributes to the wellbeing of society, and key partnerships in the private sector are critical to this effort,” said Dr Amin Hussein Al Amiri, Assistant Undersecretary for Public Health Policy and Licensing at the Ministry of Health and Prevention. “Collaborations such as